Dr. Howard Verrico reports

SIRONA BIOCHEM SIGNS AGREEMENT WITH LUXEMBOURG-BASED CURE INTELLIGENCE FOR SOCIAL MEDIA AND COMMUNICATIONS SUPPORT

Sirona Biochem Corp. has signed an agreement with Luxembourg-based analytics and marketing specialist CURE Intelligence to manage on-line analytics and social media communication.

The agreement was signed Dec. 8 and will continue for a period of 12 months.

"We realize the power of social media in bringing awareness of our technology to a greater audience both efficiently and with improved content. We have been working to increase our virtual presence and have now found a partner that can reach more potential partners and expand our business development," said Dr. Howard Verrico, chief executive officer of Sirona Biochem. "We look forward to this new relationship with the team at CURE. During our due diligence, we've been impressed with their commitment to hard work and their ability to add significant value to our communications."

"Sirona Biochem is on the verge of a new chapter in the company's history. After years of research and development of its platform technology, the company is about to commercialize one of its compounds and achieve other significant milestones. We look forward to raising awareness of Sirona and its breakthrough technology among targeted audiences through regular effective content and data-driven distribution on social media," comments Marco Feiten, managing director at CURE Intelligence.

About Sirona Biochem Corp.

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.

Sirona's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and continuing royalty payments. Sirona's laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants.

We seek Safe Harbor.